NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

Flipper, I think you did a good job of explaining your rationale. Yes, I heard her say the stats, and it's reason for me to be invested. But my caution to you is that Linda's comments on efficacy did not include any data from the phase III trial. And the phase I/II data was from a single arm trial with no control arm.

So I am not willing to conclude that we know what the benefit of the vaccine will be over the placebo, based on her comments. But I do like the anecdotal evidence that we have to date.

If your assumptions are correct, yes, we can get a recommendation for an early approval. I would never say it's impossible. I think we all are holding out some hope for it, even those of us who think it's very unlikely.